METHOD OF TREATING A PATIENT INFECTED WITH A CORONAVIRUS AND HAVING A BASELINE LEVEL OF CRP BELOW 150 MG/L

METHOD OF TREATING A PATIENT INFECTED WITH A CORONAVIRUS AND HAVING A BASELINE LEVEL OF CRP BELOW 150 MG/L

Provided herein are methods of treating a patient infected with a coronavirus and having a baseline level of CRP below 150 mg/L, comprising administering to the patient a compound of formula 1: (1) or a pharmaceutically-acceptable salt thereof. L'invention concerne des méthodes de traitement d&...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MORAN, Edmund J, LOMBARDI, David A, YATES, Wayne Arthur, SAGGAR, Rajeev, NGUYEN, Tuan Stevon, PFEIFER, Nathan David, BUDMAN, Joseph, LO, Arthur, KENNEDY, Kyla Dee-Kinnick, CRATER, Glenn D
Format: Patent
Sprache:eng ; fre
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Provided herein are methods of treating a patient infected with a coronavirus and having a baseline level of CRP below 150 mg/L, comprising administering to the patient a compound of formula 1: (1) or a pharmaceutically-acceptable salt thereof. L'invention concerne des méthodes de traitement d'un patient infecté par un coronavirus et ayant un niveau de base de CRP inférieur à 150 mg/L, comprenant l'administration au patient d'un composé de formule 1 : (1) ou d'un sel pharmaceutiquement acceptable de celui-ci.